Equities research analysts at Wedbush initiated coverage on shares of Myokardia (NASDAQ:MYOK) in a research report issued on Monday, The Fly reports. The brokerage set an “outperform” rating and a $22.00 price target on the stock. Wedbush’s price objective points to a potential upside of 77.42% from the company’s previous close. Myokardia (NASDAQ:MYOK) traded down […]
